Jump to content

Oxaceprol

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DMacks (talk | contribs) at 03:21, 22 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Oxaceprol
Clinical data
Other names(2S,4R)-1-acetyl-4-hydroxypyrrolidine-2-carboxylic acid
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
  • (4R)-1-acetyl-4-hydroxy-L-proline
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.047.058 Edit this at Wikidata
Chemical and physical data
FormulaC7H11NO4
Molar mass173.168 g·mol−1
3D model (JSmol)
  • CC(=O)N1C[C@@H](C[C@H]1C(=O)O)O
  • InChI=1S/C7H11NO4/c1-4(9)8-3-5(10)2-6(8)7(11)12/h5-6,10H,2-3H2,1H3,(H,11,12)/t5-,6+/m1/s1
  • Key:BAPRUDZDYCKSOQ-RITPCOANSA-N
  (verify)

Oxaceprol is an anti-inflammatory drug used in the treatment of osteoarthritis.[1] It is derived from L-proline, a DNA-encoded amino acid. The active effect of Oxaceprol is to inhibit the adhesion and migration of white blood cells.[2]

References

  1. ^ Herrmann G, Steeger D, Klasser M, Wirbitzky J, Fürst M, Venbrocks R, et al. (2000). "Oxaceprol is a well-tolerated therapy for osteoarthritis with efficacy equivalent to diclofenac". Clinical Rheumatology. 19 (2): 99–104. doi:10.1007/s100670050025. PMID 10791619.
  2. ^ Clayton JJ (August 2007). "Nutraceuticals in the management of osteoarthritis". Orthopedics. 30 (8): 624–9, quiz 630-1. doi:10.3928/01477447-20070801-13. PMID 17727018. Retrieved 2013-06-08.{{cite journal}}: CS1 maint: postscript (link)